ARC Desk

North America is Expected to Dominate the Immunoassay Market

Lehdistötiedote   •   Huhti 15, 2019 14:38 EEST

According to new research study, the global Immunoassay market is expected to registered growth at CAGR around 4.9% throughout the forecast period and reach around US$ 26.1 billion by 2026. Some of the key factors estimated for ensuring the development of the immunoassay market over the coming years are the technological developments in this field, together with the advent of new automated systems.

The market was led by testing for infectious diseases in 2018. In 2017, for example, more than 10 million tuberculosis cases have been registered globally and approximately 1.3 million deaths have been caused by the Centers for Disease Control and Prevention (CDC). The use of immunoassays therefore would help detect these diseases, which are expected to increase demand in the market.

Oncology, due to the increased number of cancer cases and technological advances that help to identify malignant organisms, is expected to be the fastest growing sector during the forecast period. The increase in incidence of endocrinal disorders leads to increased hospital admissions and also holds a significant market share in endocrinology. For example, in 2017, around 210,000 individuals in the U.S. were admitted every year because of acute pancreatitis, according to the Johns Hopkins Health System Corporation. Moreover, around 40 million people in the country are also affected by the osteoporosis.

Hospitals represented approximately 32.0 percent of the largest market share in 2018 because they offer advanced facilities including in-house diagnostic labs.

In recent years, the North American immunoassay market has held an enormous market share and is likely to continue to be the same for some years to come. The growth of this region will be expected to be accelerated in the coming years as geriatric populations and the development of the biotechnology and pharmaceutical industries increase. In addition, the growth of Asia-Pacific in the future will be promising, thanks to the increasing number of In recent years, the North American immunoassay market has held an enormous market share and is likely to continue to be the same for some years to come.

Market Segmentation

Immunoassay Market by Technology

  • Enzyme Immunoassay (EIA)
    • Fluorescence Immunoassays (FIA)
    • Chemiluminescence Immunoassays (CLIA)
  • Radioimmunoassay (RIA)
  • Rapid test
  • Others

Immunoassay Market by Product

  • Analyzers/instruments
    • Closed ended systems
    • Open ended systems
  • Reagents & kits
  • Software & services

Immunoassay Market by Application

  • Endocrinology
  • Therapeutic drug monitoring
  • Autoimmune diseases
  • Infectious disease testing
  • Cardiology
  • Others

Immunoassay Market by End-Use

  • Hospitals
  • Pharmaceutical and biotech companies
  • Clinical laboratories
  • Academic research centers
  • Blood banks
  • Others

Global Immunoassay Market, by Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA
  • Market Participants

    The key players of the market are Dickinson & Company; Becton, Thermo Fisher Scientific, Inc.; BioMérieux; Siemens Healthineers; Abbott laboratories; Roche Diagnostics; Sysmex Corporation; Danaher Corporation; Ortho Clinical Diagnostics; and Quidel Corporation.

    Get the Sample Copy of Report, Visit@